4.6 Article

Effects of Combination Denosumab andHigh-DoseTeriparatide Administration on Bone Microarchitecture and Estimated Strength: TheDATA-HD HR-pQCTStudy

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT

Sabashini K. Ramchand et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Cell Biology

Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate

Yi Fan et al.

CELL METABOLISM (2017)

Article Endocrinology & Metabolism

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

J. N. Tsai et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Endocrinology & Metabolism

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women

Henry G. Bone et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Review Medicine, General & Internal

Mechanisms of anabolic therapies for osteoporosis

Ernesto Canalis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Endocrinology & Metabolism

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

O. Johnell et al.

OSTEOPOROSIS INTERNATIONAL (2006)

Article Endocrinology & Metabolism

In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography

S Boutroy et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Endocrinology & Metabolism

Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure

YB Jiang et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2003)

Article Endocrinology & Metabolism

An assessment tool for predicting fracture risk in postmenopausal women

DM Black et al.

OSTEOPOROSIS INTERNATIONAL (2001)